Sera Prognostics, Inc. (SERA)
Sera Prognostics Market Cap : 74.76M for May 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Co-Diagnostics, Inc. | 3.268M |
| Celldex Therapeutics, Inc. | 2.151B |
| Plus Therapeutics, Inc. | 41.79M |
| Atossa Therapeutics, Inc. | 46.20M |
| Abeona Therapeutics, Inc. | 309.78M |
Market Cap Related Metrics
| PS Ratio | 1123.24 |
| Price to Book Value | 0.9915 |
| Price | 1.91 |
| Earnings Yield | -35.32% |